Search Results
Showing 1 of 1 search results for:
Study of CC-93269, a BCMA x CD3 T Cell Engaging Antibody, in Subjects With Relapsed and Refractory Multiple Myeloma
Status
Condition
Multiple Myeloma
Phase
INTERVENTION
Drug: CC-93269
Eligibility
Ages Eligible for Study :
Sexes Eligible for Study : All
Accepts Healthy Volunteers :
Result 1 of 1